Jeff O'Hagan Email & Phone Number

West Coast / Los Angeles

Greater Los Angeles Area

Notable successes: expertise in navigating clinical trial regulations involving psychedelic and pain/addiction studies involving scheduled drugs (1-4); DEA regulations and relations.

Pasedena, Ca

Notable successes: niche experience and expertise in surgical trials involving acute pain indications and therapies (opiate sparing, non opiate analgesics)

New York, New York

Notable success: helped initiate Roche's involvement into rare disease / Spinal Muscular Atrophy program from an operational and strategic capacity. Clinical Study Leader - Roche TCRC group in Pharma Research and Early Development (pRED). Responsible for the conduct and execution of early phase trials in multi therapeutic disciplines with an emphasis in oncology and rare disease.

Notable successes: Assisted in the bid defense for securing an award of three large Phase 3 registration studies for the indication of Alzheimer's Disease. Served as Associate Director / Global PM on the program from start-up through conduct. Managed Japan and South Korea for 2 years; experienced with local regulations, contracts and relations in this challenging region.

Home Based

Notable successes: Vendor management assisting with the filing preparations (FDA and PMDA) for orphan drug indications in rare disease (Pompe and Gaucher).

Nutley, Nj

Notable successes: Assisted with FDA filing of Zelboraf, a first line treatment for late stage metastatic melanoma. Involved with life cycle trials for multiple oncologic compounds in Roche/Genetech's exceptionally strong therapeutic pipeline.

Nutley, Nj

Notable successes: Managed multiple post marketing/RWE trials involving treatments for Hepatitis C (PEGASYS and COPEGUS).

Notable successes: 2002 Monitor of the Year Award (ratings were based on audit findings, query rate, CRF retrieval and travel time spent for the year)SCIREX mentor - selected by management to partake in the company mentor program, designed to observe and train newly hired CRAs.

Notable successes: Coordinated and managed IP supply for a long-term post marketing mega trial involving 300 sites in the indication of hyperlipemia (Zocor).

Notable successes: Assisted with the final collection of study data for the IND submission of Cozaar/Hyzaar (anti-hypertensives).